Firebrick Pharma Limited (AU:FRE) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited has launched its Nasodine Nasal Spray in Singapore, available for online purchase with consumer advertising approved by the Health Sciences Authority. Promoted as a germ-killing nasal spray, Nasodine is a ‘first-in-class’ product in the region, with potential future sales through pharmacies and partnerships. The product is priced at SGD 24.99 per bottle and is the first PVP-I nasal spray in Singapore, targeting increased consumer awareness post-COVID.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.